The temporal gene expression profile during the entire process of apoptosis and cell cycle progression in response to p53 in human ovarian cancer cells was explored with cDNA microarrays representing 33 615 individual human genes. A total of 1501 genes (4.4%) were found to respond to p53 (approximately 80% of these were repressed by p53) using 2.5-fold change as a cutoff. It was anticipated that most of p53 responsive genes resulted from the secondary effect of p53 expression at late stage of apoptosis. To delineate potential p53 direct and indirect target genes during the process of apoptosis and cell cycle progression, microarray data were combined with global p53 DNA-binding site analysis. Here we showed that 361 out of 1501 p53 responsive genes contained p53 consensus DNA-binding sequence(s) in their regulatory region, approximately 80% of which were repressed by p53. This is the first time that a large number of p53-repressed genes have been identified to contain p53 consensus DNAbinding sequence(s) in their regulatory region. Hierarchical cluster analysis of these genes revealed distinct temporal expression patterns of transcriptional activation and repression by p53. More genes were activated at early time points, while more repressed genes were found after the onset of apoptosis. A small-scale quantitative chromatin immunoprecipitation analysis indicated that in vivo p53-DNA interaction was detected in eight out of 10 genes, most of which were repressed by p53 at the early onset of apoptosis, suggesting that a portion of p53 target genes in the human genome could be negatively regulated by p53 via sequence-specific DNA binding. The approaches and genes described here should aid the understanding of global gene regulatory network of p53.
The temporal gene expression profile during the entire process of apoptosis and cell cycle progression in response to p53 in human ovarian cancer cells was explored with cDNA microarrays representing 33 615 individual human genes. A total of 1501 genes (4.4%) were found to respond to p53 (approximately 80% of these were repressed by p53) using 2.5-fold change as a cutoff. It was anticipated that most of p53 responsive genes resulted from the secondary effect of p53 expression at late stage of apoptosis. To delineate potential p53 direct and indirect target genes during the process of apoptosis and cell cycle progression, microarray data were combined with global p53 DNA-binding site analysis. Here we showed that 361 out of 1501 p53 responsive genes contained p53 consensus DNA-binding sequence(s) in their regulatory region, approximately 80% of which were repressed by p53. This is the first time that a large number of p53-repressed genes have been identified to contain p53 consensus DNAbinding sequence(s) in their regulatory region. Hierarchical cluster analysis of these genes revealed distinct temporal expression patterns of transcriptional activation and repression by p53. More genes were activated at early time points, while more repressed genes were found after the onset of apoptosis. A small-scale quantitative chromatin immunoprecipitation analysis indicated that in vivo p53-DNA interaction was detected in eight out of 10 genes, most of which were repressed by p53 at the early onset of apoptosis, suggesting that a portion of p53 target genes in the human genome could be negatively regulated by p53 via sequence-specific DNA binding. The apIntroduction p53 is a central regulator of cell growth, DNA damage repair, and apoptosis (Vogelstein and Levine, 2000) . It is a transcription factor that specifically recognizes DNA sequences containing two adjacent copies of the consensus sequence 5 0 -RRRCWWGYYY(N ¼ 0-13)RRRCWWGYYY-3 0 (El-Deiry et al., 1992) . In this motif, R ¼ G or A, W ¼ T or A, Y ¼ C or T, N ¼ any base. p53 directly activates the expression of a substantial number of genes important for cell cycle regulation and apoptosis, through binding to the p53 DNA-binding site(s) (El-Deiry et al., 1993; Hollander et al., 1993; Buckbinder et al., 1995; Miyashita and Reed, 1995; Ludes-Meyers et al., 1996; Morris et al., 1996) .
Identification of transcriptional targets of p53 is of great importance in understanding the pathways by which p53 regulates growth arrest and apoptosis. Recent studies using microarray or SAGE analysis aimed at identifying differentially expressed genes in response to p53 have yielded valuable insights into these mechanisms (Madden et al., 1997; Polyak et al., 1997; Yu et al., 1999; Maxwell and Davis, 2000; Zhao et al., 2000) . Although numerous genes have been identified, a mixed readout of direct and indirect p53 target genes is obtained from these experiments. In a recent study, we reported on a p53 Target Database, consisting of 4852 human genes that contain at least one p53 consensus binding sequence in their regulatory region . Availability of this database provides an important tool for identifying p53 target genes at the genomic scale.
In contrast to transcriptional activation, most genes reported to be repressed by p53 lack a classical p53-binding site in their promoter (Gopalkrishnan et al., 1998; Kaluzova et al., 2000; Krause et al., 2000) . Several mechanisms have been proposed for p53-mediated repression, including the sequestration of components of the basal transcription machinery by p53 (Liu et al., 1993; Lu and Levine, 1995; Gopalkrishnan et al., 1998) , regulation by histone deacetylases (Murphy et al., 1999; Mirza et al., 2002) , or interaction with other transcription factors (Agoff et al., 1993; Borellini and Glazer, 1993; Desdouets et al., 1996; Maiyar et al., 1997) . In a few cases, it has been proposed that p53 represses transcription through direct DNA binding (Ori et al., 1998; Budhram-Mahadeo et al., 1999; Lee et al., 1999; Hoffman et al., 2002) .
In this study, a temporal expression profile of human genes downstream of p53 was determined, using cDNA microarray evaluation of RNA derived from a human ovarian cancer cell line (2774qw1) infected with adenovirus expressing p53 (rAd-p53) or adenovirus containing empty vector (rAd-empty vector). The microarray data integrated with the p53 Target Database provide a compilation of potential p53 direct target genes. Quantitative chromatin immunoprecipitation (ChIP) analysis was used to confirm the in silico prediction.
Results

Optimization of rAd-p53 treatment for microarray experiments
In an attempt to define p53 target genes, we used adenovirus vector-mediated transduction of wild-type p53 in a human ovarian cancer cell line, 2774qw1, that carries a mutant p53 . 2774qw1 cells were infected with 1 Â 10 9 particle/ml, 5 Â 10 9 particle/ ml, or 1 Â 10 10 particle/ml of rAd-p53 or rAd-empty vector for 1 h, and infected cells were harvested at 0, 2, 4, 8, 16, 24, or 40 h postinfection. The dose-dependent expression of p53 was observed after infection with an increasing dose of rAd-p53 (data not shown). The results from DNA fragmentation assays showed timeand dose-dependent apoptotic effects with rAd-p53 infection, while all doses of rAd-empty vector infection showed minimal effect (data not shown). Exogenous p53 expression in 2774qw1 cells infected with 10 10 particle/ml rAd-p53 became detectable as early as 4 h postinfection at the mRNA level and 6 h postinfection at the protein level . The transduction efficiency was estimated to be approximately 86-89% in these cells 2-24 h after infection with 1 Â 10 10 particle/ml of adenovirus expressing b-galactosidase . Therefore, the concentration of 10 10 particle/ml rAd-p53 was used to produce the greatest p53 effect.
In order to correlate the transcriptional response of genes to p53 expression with phenotype of p53 action, temporal apoptotic response and cell cycle progression were monitored on cells infected with rAd-p53 or rAdempty vector under the identical conditions where RNA was isolated for microarray hybridization. rAd-p53-induced DNA fragmentation, a hallmark of apoptosis, started 12 h postinfection, and reached a peak at 20 h, while rAd-empty vector infection had minimal effect ( Figure 1a) . Furthermore, we used simultaneous staining with both the cell-impermeable dye 7-AAD and annexin V-PE to classify apoptotic cells into early and late stages of apoptosis. (Figure 1b Intermediate annexin V-and 7-AAD-positive cell populations were detected at 16 h postinfection of rAdp53, but not at 12 h as compared with the control sample ( Figure 1b) . Therefore, the temporal apoptotic profile of 2774qw1 cells infected with rAd-p53 can be divided into three stages: (1) before initiation of apoptosis (4 and 8 h postinfection), (2) early onset of apoptosis (12 and 16 h postinfection), and (3) late apoptosis (20 and 24 h postinfection). In addition, FACS analysis indicated that substantial G1 arrest took place at 20 and 24 h postinfection in cells infected with rAd-p53 . Since we wanted to monitor the expression profile of p53 responsive genes during the entire process of apoptosis and cell cycle progression, mRNA was isolated at six time points (4, 8, 12, 16, 20 and 24 h postinfection) for microarray hybridization.
Genome-wide identification of p53 direct target genes mRNA was isolated from cells at 4, 8, 12, 16, 20 , or 24 h postinfection with 10 10 particle/ml rAd-p53 or rAdempty vector, and subjected to hybridization using six Incyte GeneAlbum microarrays, containing approximately 60 000 cDNAs (33 615 individual genes). At each time point, mRNA isolated from cells infected with rAdp53 was used to prepare cDNA labeled with Cy5-dUTP, and mRNA from cells at the corresponding times postinfection of rAd-empty vector was used to prepare cDNA labeled with Cy3-dUTP. The two cDNA probes were mixed and simultaneously hybridized to the microarray as described under 'Materials and methods'. The hybridization results from all six microarrays were compiled and analysed based on fold change compared to the control (rAd-empty vector infection). The differential expression of several known p53 target genes was examined to ensure the reliability of the microarray hybridization results. It was found that PIG3 (3-13.4-fold) and p21 WAF1/Cip1 (4.2-7.6-fold) were activated at all time points tested, and GADD45 (2.9-4.2-fold) was induced at early time points (4-8 h postinfection). Cyclin B1 was repressed (2.5-fold) at 8 h postinfection. The genes that showed 2.5-fold or greater changes in at least one time point were selected for further analysis. The temporal distribution of p53 responsive genes is summarized in Table 1 . We observed that 30 cDNAs showed differential expression at 4 h postinfection (Table 1) . The number of genes expressed in response to p53 dramatically increased after 12 h postinfection and reached a peak at 16 h (Table 1 ). In total, 1501 genes (4.4%) responded to p53 expression in one or more time points using 2.5-fold change as a cutoff.
Unexpectedly, the microarray data indicated that transcriptional repression of genes in 2774qw1 cells infected with rAd-p53 was frequent (Table 1) . To evaluate whether this was owing to a bias of dye labeling, reverse-fluorescence hybridization experiments were carried out with reverse fluorescent dye labeling of two probes on one microarray, GEM_3, with the same batches of mRNA used in the microarray experiments described above. In the first experiment, the results indicated that 147 cDNAs (26 activated and 121 repressed) exhibited differential expression in response to p53. The second experiment, where the probes were labeled with the reverse fluorescent dye, yielded 170 cDNAs (17 activated and 153 repressed) that show differential expression in response to p53. Together, 118 cDNAs showed differential expression in response to p53 in both experiments and all exhibited the same trend of induction or repression by p53 (15 activated and 103 repressed). The results suggest that the high frequency of repression of gene expression in response to p53 was not because an incidence of color bias.
Although cDNA microarray technology is powerful, the readout gave both p53 direct and indirect target genes. In a recent study, we identified 4852 human genes that contain at least one p53 consensus binding sequence in their regulatory region in the human genome . Of these, 3387 (70%) are represented on the six Incyte GeneAlbum microarrays. The microarray data integrated with the p53 Target Database yields candidates for p53 direct target genes. In total, 67 activated genes and 294 repressed genes were found to have a p53 DNA-binding sequence(s) (Supplementary Information, S1 and S2). Two known p53 target genes, PIG3 and GADD45, were included. p21 WAF1/Cip1 was activated but not identified by this analysis since its p53 response element is located more than 2 kb from its transcriptional start site, the cutoff size of the promoters used for computational analysis .
Hierarchical cluster analysis
To examine the global expression profile of p53 target genes, we performed hierarchical cluster analysis based on similarity of expression patterns of genes. Genes in the analysis were selected if they were differentially expressed with at least 2.5-fold change at one or more time points and had not more than one missing value out of six data points in the time course. Using these criteria, 348 p53 target genes were included in the analysis. We used an unsupervised hierarchical 
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Global transcriptional program of p53 target genes A Mirza et al clustering algorithm to group genes based on similarity in their pattern of expression across the time course (Figure 2) . Green boxes represent genes with increased expression and red boxes genes with decreased expression. The magnitude of the change is depicted by the intensity of color. In total, 21 clusters were discerned. Among these, at least six major gene expression patterns were detected, shown by color bars A-F, and the expression profile of individual genes in each major cluster was plotted with fold change versus time point (Figure 2 p53 binds to some of the repressed genes in vivo in a DNA sequence-specific manner Our data indicated that 294 genes repressed by p53 have at least one p53 consensus DNA-binding sequence in their regulatory region, suggesting that some of the repressed genes might be regulated via direct p53 binding to DNA. To further address this possibility, we used ChIP technique to detect in vivo binding of p53 to the predicted p53-binding sequences in intact cells. We focused on 11 genes repressed by p53. Differences in transcriptional activity of these genes detected in the microarray experiments were first confirmed by realtime quantitative RT-PCR. Of these, only alpha tubulin failed to confirm, showing unchanged mRNA level upon infection of rAd-p53. The ChIP assays were performed on the predicted p53 DNA-binding sites in the promoter of 10 genes (Table 2) . 2774qw1 cells at 16 h postinfection with rAd-p53 or virus control were treated with formaldehyde to crosslink proteins to DNA. After sonication, the crosslinked chromatin was immunoprecipitated with p53-specific antibody. The crosslinked protein is then removed from DNA by proteolysis. Finally, the immunoprecipitated DNA is analysed by quantitative PCR to determine which potential DNAbinding sites are bound by p53. Taqman primers were designed to generate a PCR amplicon that either overlapped with or was a few nucleotides from the predicted p53-binding site. Taking Transient Receptor Potential Channel 7 gene as an example, in silico prediction gave putative p53-binding sites located À1437 and À1446 bp upstream of the transcription start site, which overlapped each other ( Figure 3a and Table 2 ). The DNA fragment containing the p53-binding sites was examined by ChIP. Quantitative PCR with the site-specific PCR primers, BChIP1, detected the enrichment of the fragments harboring the predicted p53-binding site at nucleotides À1437 to À1446 compared to the control sample ( Figure 3b ). As expected, not all predicted p53-binding sequences are bound by p53 in vivo. For example, the gene encoding Zeta-crystallin has three putative sites started at À491, À1832, and À1836. The latter two sites overlap. No significant amounts of DNA fragments were detected containing the two predicted sites from nucleotide À1832 to À1858. However, a fraction of the DNA fragment containing the site started from nucleotide À491 was found in association with the anti-p53 chromatin immunoprecipitate ( Figure 3b ). As negative controls, chromatin was immunoprecipitated either in the absence of p53 specific antibody, or from control virus-infected cells. Negligible amounts of the DNA fragment were detected in these immunoprecipitates. As a positive control, we included a reaction containing a known p53-binding site in the promoter of proliferating cell nuclear antigen gene, which gave the expected results (data not shown). Alpha tubulin, which contains a putative p53 DNA-binding site and was not differentially expressed in response to p53 in quantitative RT-PCR analysis, was used as a negative control and showed no detectable enrichment of DNA fragments containing the putative p53-binding sequence (data not shown). The ChIP assays were considered positive if the enrichment of DNA fragments containing the predicted p53-binding sequence(s) was three fold greater than no antibody control in at least four out of five independent experiments. The results of ChIP assays of 10 genes are summarized in Table 2 , and the results of all ChIPpositive p53 DNA-binding sites in eight genes are shown in Figure 3b .
Discussion
In this study, we performed a temporal expression profiling of human genes in response to p53 in 2774qw1 human ovarian cancer cells infected with rAd-p53 or rAd-empty vector on 60 000 cDNA microarrays, representing 33 615 unique genes. We have identified 1501 genes that respond to p53. By integration of the microarray data and the p53 Target Database, it was (GI No. 5499741) cAGCATGCTTagcctcAGGCcTGgCT ( (Madden et al., 1997; Polyak et al., 1997; Yu et al., 1999; Maxwell and Davis, 2000; Zhao et al., 2000) . These studies focused on early p53 responses before the onset of apoptosis and found more genes activated than repressed by p53. Our data are in agreement with these studies and showed that more genes were activated (19 out of 27) at early time points (4 and 8 h postinfection) before the initiation of apoptosis.
In our study, we looked for p53 responsive genes during the entire process of apoptosis and cell cycle progression (4-24 h postinfection of rAd-p53). One of the most striking features in the hierarchical cluster analysis (Figure 2) is that the temporal expression patterns of p53-activated genes (clusters A and B) are markedly different from those for p53-repressed genes (clusters C-F). Many more genes (334) exhibited differential expression from 12 to 24 h postinfection with rAd-p53. Most of them were repressed by p53. The further reverse fluorescent hybridization experiments suggested that the observed high frequency of repression by p53 did not result from a bias of dye labeling. Although there are several cases where p53 can repress transcription through direct interaction of its consensus DNA-binding site, genome-wide analysis of p53-mediated repression has not been explored yet. This is the first time that a large number of p53-repressed genes have been identified containing p53 consensus DNA-binding sequence(s) in their regulatory region. In principle, genes directly regulated by p53 should respond to p53 expression more quickly than secondary responsive genes. It was anticipated that high population of genes in response to p53 resulted from the secondary effect of p53 expression at the late stage of apoptosis. However, an early response might become detectable at relatively late time points as the transcripts accumulate. It is not easy to pinpoint the best sampling time to enrich for p53 direct target genes. Obviously, the overlap of p53 responsive genes with those present in the p53 Target Database provides most likely candidates for p53 direct target genes. In our previous study, we developed an 'Enrichment Factor' (EF) analysis, which estimates the significance of an observed degree of in silico prediction with microarray data . The temporal EF analysis suggested that p53-repressed genes responded to p53 slower than activated genes, and reached a peak around 12 h postinfection of rAd-p53. This may reflect the difference in the nature of the mechanisms of p53-mediated transcriptional activation and repression in gene expression, and/or the role in the execution of p53 function. p53 could transcriptionally activate gene expression by direct DNA binding (El-Deiry et al., 1993; Hollander et al., 1993; Juven et al., 1993; Buckbinder et al., 1995) whereas p53 may mediate transcriptional repression by competitive DNA binding to displace another activator binding (Ori et al., 1998; Budhram-Mahadeo et al., 1999; Lee et al., 1999; Hoffman et al., 2002) .
To further validate direct p53 interaction with p53-repressed genes in intact cells, quantitative chromatin immunoprecipitation (ChIP) assay was used. At first, eight genes repressed by p53 started from 12 h postinfection were selected ( Table 2 ). The results of ChIP assays indicated that the promoter fragments containing p53-binding sites were enriched from six of eight p53-repressed genes following immunoprecipitation with a p53-specific antibody (Table 2 and Figure 3) . Two additional genes repressed by p53 at different time points were selected for ChIP assays. One gene encoding unnamed protein product was repressed from 8 to 24 h postinfection and the other one encoding stearoyl-CoA desaturase repressed from 16 to 24 h postinfection (Table 2 ). Both showed positive in vivo p53-DNA interaction in the ChIP assays. This agrees with the previous observation made by EF analysis , and suggests that a portion of p53-repressed genes in the human genome be regulated by p53 in a DNA sequence-specific manner. Taken together, small-scale quantitative ChIP analyses carried out in our laboratory suggested that p53 occupies the predicted p53 DNA-binding sites in six out of six p53-activated genes tested , and eight of 10 p53-repressed genes tested in vivo. The number of p53 target genes could be estimated at approximately 300 out of 362 direct targets of p53 if we assume that 20% of the p53-repressed genes and none of the p53-activated genes identified above are false positives. This number is close to the number of human p53-tagged sites in the human genome estimated by a yeast-based screening method (Tokino et al., 1994) .
One of the most intriguing aspects of genomic analyses is the amount of extremely detailed information that lends itself to a global framework for understanding complex patterns in cells in response to p53. As expected, a large number of genes showed differential expression (mostly repression) after the onset of apoptosis, likely because of secondary response to p53. Interestingly, we observed that p53 represses the expression of genes encoding 19 transcription factors (mostly enhancers), eight proteins associated with general transcription and six proteins involving in RNA processing after 12 h postinfection (Supplementary Information S2). This may explain in part why many differentially expressed genes were repressed following the onset of apoptosis. In addition, we observed that the TBP-associated factor 172 was repressed by p53 at later time points. The binding of p53 to TATA-binding protein has been implicated in p53-mediated transcriptional repression (Seto et al., 1992) . This may reflect a negative feedback pathway in the modulation of p53 function as a transcription repressor. p53 also repressed genes involved in posttranscriptional regulation, including the genes involved in translation. These are genes encoding eucaryotic translation initiation factor 3 subunit 7, UNR protein, translation initiation factor eIF-4A I, eucaryotic peptide chain release factor subunit 1. Hence, p53 may modulate the production of functional proteins that are important in apoptosis and/or cell cycle progression at several levels, including transcriptional repression, inhibition of RNA processing, and blocking translation of proteins in 2774qw1 ovarian cancer cells.
In a recent study, a novel mechanism of p53 repression was proposed, which involves the specific binding of p53 to an atypical site within the MDR1 promoter (Johnson et al., 2001) . Unlike the traditional head-to-head arrangement, this site is arranged in a head-to-tail orientation: 5 0 -RRRCWN{0-1}RRRCW-3 0 N{0-13}RRRCW{0-1}RRRCW), suggesting that the orientation of the half-site in the p53-binding site determines the fate of p53-regulated promoters (Johnson et al., 2001) . We have analysed the distribution of the genes containing the novel p53 repression responsive element in the human genome, which will be the subject of further investigation (Wang L and Liu S, unpublished results) .
The genes identified in this study appear to involve broad functional classes and multiple gene families. p53 expression was found to regulate transcriptionally a number of intracellular regulatory proteins, such as kinases and phosphatases. Polyak et al. observed that p53 transcriptionally activates a number of reduction-oxidation-related genes during the process of p53-induced apoptosis (Polyak et al., 1997) . As expected, a number of reduction-oxidation-related genes, including a known p53 target gene PIG 3, showed differential expression following p53 expression. Several proteases and protease inhibitors were transcriptionally regulated by p53 after the onset of apoptosis and late apoptosis. It has been shown that transfection of various proteases into cells can induce apoptosis although it remains unclear whether these proteases ultimately activate caspases (Thompson, 1998) . It is interesting to note that p53 induced both the creatine transporter and ABC transporter before the onset of apoptosis. p53 also repressed several transporters after the onset of apoptosis: the calcium-binding transporter, transferrin receptor 2 alpha, the calcium-binding mitochondrial carrier protein aralar2, an organic anion transporter (isoform 2), cation-dependent mannose-6-phosphate receptor precursor, and sialin. It is possible that the inhibition of expression of transporters by p53 is involved in the signal to trigger apoptosis. Other transcripts encoding annexin I, annexin V, and annexin VII isoform 2 were repressed by p53 in the microarray experiments after the onset of apoptosis. Dysregulation of annexin expression and activity has been correlated with human diseases, including cancers (Gerke and Moss, 2002) , and p53 may induce apoptosis by blocking these annexins.
In short, the approaches described here illustrate the great advantage of combining expression profiling and global p53 DNA-binding site analysis, which provides a new view of the global gene regulatory network of p53 and will assist in the identification of potential therapeutic targets that bypass the requirement of p53 for cancer therapy. The application of these approaches to other cellular systems or other oncogenic transcription factors will help to analyse global gene regulatory networks.
Materials and methods
Cell line and cell culture
The cell line 2774qw1 is a single clone derived from human ovarian cancer cell line 2774, which was obtained from American Type Cell Collection . Culture conditions for 2774qw1 cells followed vender's instruction for the 2774 cell line.
Treatment of cells with recombinant adenoviruses
2774qw1 cells were infected with 10 10 particle/ml of rAd-p53, or rAd-empty vector for 1 h and replaced with fresh media after washing with PBS. The infected cells were harvested at indicated time points and cell pellets were prepared for apoptosis assays, RNA isolation and chromatin immunoprecipitation. The adenovirus vectors have been described previously .
RNA isolation and quantitative RT-PCR
RNA preparation and quantitative RT-PCR was performed as described previously . The fold change of mRNA level in the samples infected with rAd-p53 at each time point was calculated as fold change relative to that in the samples infected with rAd-empty vector at the corresponding time point. All measurements were done in at least two independent experiments, each of which was done in triplicate. Sequences of the primers and probes for five apoptosis-or cell cycle-related genes were the same as described previously (Wen et al., 2000) .
Apoptosis analyses
Cell Death Detection ELISA PLUS (Roche, Indianepolis, IN) was used to measure DNA fragmentation. In addition, Nexint assay (Guava, Inc., Hayward, CA) was used for discrimination of early and late apoptotic cells. Apoptosis analyses followed the manufacturer's instruction.
cDNA microarray hybridization
The microarray experiments were performed at Incyte Genomics (Palo Alto, CA). Briefly, total RNA was purified from 2774qw1 cells infected with 10 10 particle/ml of rAd-p53 or rAd-empty vector at various time points. For each probe pair, Poly (A) mRNA was isolated from approximately 200 mg of total RNA using oligotex beads (Qiagen, Chatsworth, CA, USA). Labeled cDNA was prepared by reverse transcription with Cy3-deoxyuridine triphosphate (dUTP) and Cy5-dUTP fluorescent dyes for microarray hybridization to GeneAlbum 1-6 (Incyte Genomics, Palo Alto, CA) as described (DeRisi et al., 1997) . The two fluorescent colors (Cy3 and Cy5) obtained with appropriate excitation and emission filters constitute the raw data from which differential gene expression ratio was calculated. Differential efficiencies of labeling and detection of Cy3 and Cy5 signals were normalized as described (Yue et al., 2001) . The ratio of two normalized probe signals yielded differential expression of genes in response to p53.
Quantitative ChIP assays
The ChIP assays were performed as described previously . The sequences of primers and probe in ChIP assays, obtained from Perkin Elmer Applied BioSystems (Fostercity, CA), are listed in Supplementary Information, S3 . 
Statistical analyses
The p53 target genes were grouped according to the similarity of their expression patterns using a hierarchical clustering method described by Eisen et al. (1998) . The clustering algorithm was implemented using the software package S-PLUS (Mathsoft Inc., Seattle, WA, USA).
Abbreviations rAd-p53, adenovirus expressing p53; rAd-p21, adenovirus expressing p21 WAF1/Cip1 ; rAd-empty vector, adenovirus containing an empty vector; ChIP, chromatin immunoprecipitation; RT-PCR, reverse transcription PCR; EF, enrichment factor.
